在商业保险患者中为口服伦瓦提尼布的成本共享
Margaret I Liang1, Ling Chen, Emeline M Aviki
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, 8635 W 3rd St, Ste 160W, Los Angeles, CA 90048.
The American journal of managed care
|March 8, 2024
概括
商业保险的癌症患者处方伦瓦提尼布 (Lenvima) 的自付费用很低,75%的患者每月支付100美元或更少. 这项研究强调了需要财政援助计划来解决高药费用和潜在的患者障碍.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 制药政策 制药政策
背景情况:
- 伦瓦提尼布 (Lenvima) 是一种向疗法,用于治疗各种癌症,包括甲状腺癌,细胞癌,肝细胞癌和子宫内膜癌.
- 了解成本共享趋势对于评估患者获得必要的癌症药物至关重要.
- 之前的研究还没有完全阐明商业保险人群中伦瓦提尼布的成本共享格局.
研究的目的:
- 评估商业保险癌症患者的伦瓦提尼布 (Lenvima) 的成本共享趋势.
- 分析lenvatinib处方的总体趋势,保险责任,福利协调和自付费用.
- 识别患者获得伦瓦提尼布的潜在财务障碍.
主要方法:
- 利用了IBM MarketScan数据库,包括2015-2019年全国制药索赔.
- 包括那些至少有一个门诊药物索赔的患者,这些患者在非总体基础上使用了伦瓦提尼布.
- 估计30天供应的中位数和IQR成本,经通货膨胀调整至2019美元.
主要成果:
- 总共包括了685名患有各种癌症的患者.
- 伦瓦提尼布的30天中位成本为17.253美元,保险覆盖了大部分.
- 75%的患者的自付费用为每月100美元或更少;然而,一些患者面临着显著更高的成本 (最高为12538美元).
结论:
- 保险有效地支付了大部分的lenvatinib费用,这导致大多数患者的自付费用很低.
- 尽管自付费用中位数较低,但有一部分患者经历了相当大的财务负担.
- 建议加强财政援助计划和政策改革,以减轻高昂的药物成本,并确保患者获得伦瓦提尼布.
相关概念视频
Nursing Ethical Principles II
965
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
965
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
166
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


